Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

Published:2019-08 Issue:8 Volume:30 Page:1321-1328
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Mazieres J.^ORCID,Drilon A.,Lusque A.,Mhanna L.,Cortot A.B.,Mezquita L.,Thai A.A.,Mascaux C.,Couraud S.,Veillon R.,Van den Heuvel M.,Neal J.,Peled N.,Früh M.,Ng T.L.,Gounant V.,Popat S.,Diebold J.,Sabari J.,Zhu V.W.,Rothschild S.I.,Bironzo P.,Martinez-Marti A.,Curioni-Fontecedro A.,Rosell R.,Lattuca-Truc M.,Wiesweg M.,Besse B.,Solomon B.,Barlesi F.,Schouten R.D.,Wakelee H.,Camidge D.R.,Zalcman G.,Novello S.,Ou S.I.,Milia J.,Gautschi O.

Funder

Toulouse University Hospital

Lucerne Cantonal Hospital

Novartis

Roche/Genentech

Pfizer

Astrazeneca

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/advance-article-pdf/doi/10.1093/annonc/mdz167/28848279/mdz167.pdf

Reference29 articles.

1. Treatment of advanced non-small cell lung cancer in 2018;Doroshow;JAMA Oncol,2018

2. Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas;Cortot;Eur Respir Rev,2014

3. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016

4. Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC;Socinski;N Engl J Med,2018

Cited by 942 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of resistance to immunotherapy;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. ROS1-rearranged non-small cell lung cancer: Understanding biology and optimizing management in the era of new approvals;Current Problems in Cancer;2024-12

3. Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience;The Journal of Liquid Biopsy;2024-12

4. Analysis of immune checkpoint inhibitors for advanced non-small cell lung cancer in patients receiving antacids;Respiratory Investigation;2024-11

5. Different pathways to lung cancer diagnosis in a real-life setting;Respiratory Medicine and Research;2024-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3